More issues

How to Get Uplizna (Inebilizumab) Covered by Blue Cross Blue Shield in New Jersey: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Uplizna (Inebilizumab) Covered by Blue Cross Blue Shield in New Jersey Uplizna (inebilizumab) requires prior authorization from Blue Cross Blue Shield for AQP4-positive NMOSD or IgG4-related disease. In New Jersey, your fastest path to approval involves: (1) confirming AQP4-IgG positive test results via cell-based assay, (2) documenting
6 min read

How to Get Cosentyx (secukinumab) Covered by Cigna in New Jersey: Prior Authorization, Appeals, and Formulary Alternatives

Answer Box: Getting Cosentyx (secukinumab) Covered by Cigna in New Jersey Fastest path to approval: Have your rheumatologist or dermatologist submit a prior authorization request documenting trial/failure of preferred alternatives like Tremfya (guselkumab) and meet age/specialist requirements. If denied, you have 180 days for internal appeals, then external
5 min read

How to Get Vanflyta (Quizartinib) Covered by Cigna in Washington: Complete Prior Authorization & Appeals Guide

Answer Box: Getting Vanflyta (Quizartinib) Covered by Cigna in Washington Cigna requires prior authorization for Vanflyta (quizartinib) in FLT3-ITD-positive AML patients ≥18 years old with confirmed mutation via FDA-approved testing. Submit comprehensive documentation including baseline ECG showing QTc <450ms, REMS enrollment proof, and oncologist's medical necessity letter.
5 min read

How Long Does It Take to Get Busulfex (Busulfan Injection) Approved by Blue Cross Blue Shield in New Jersey? Timeline & Appeal Process

Answer Box: Getting Busulfex Approved in New Jersey Blue Cross Blue Shield plans in New Jersey require prior authorization for Busulfex (busulfan injection, HCPCS J0594) used in transplant conditioning regimens. Standard approvals take 9-12 calendar days, while urgent requests for transplant conditioning receive decisions within 24-72 hours. Coverage falls under
7 min read

How to Get Tepezza (Teprotumumab) Covered by Aetna CVS Health in Virginia: Complete Prior Authorization and Appeals Guide

Quick Answer: Aetna CVS Health covers Tepezza for moderate-to-severe thyroid eye disease in Virginia with mandatory prior authorization requiring ophthalmologist evaluation, Clinical Activity Score ≥4, and documented steroid failure. Submit PA through CVS Specialty Pharmacy coordination. If denied, Virginia's Bureau of Insurance offers external review within 120 days
7 min read